|
시장보고서
상품코드
2038383
수면무호흡증용 기기 시장 : 시장 비즈니스 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)Sleep Apnea Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 수면무호흡증용 기기 시장은 2025년에 93억 달러로 평가되었고, CAGR 7.2%로 성장할 전망이며, 2035년까지 187억 달러에 이를 것으로 예측됩니다.
수면무호흡증용 기기 산업은 수면 관련 호흡장애의 유병률 증가, 인식 증가, 지속적인 기술 혁신으로 인해 꾸준히 성장하고 있습니다. 컴팩트하고 효율적이며 고성능의 치료 솔루션에 대한 수요가 증가함에 따라 시장 상황이 새롭게 변화하고 있습니다. 노화에 따른 질병이 수면장애에 크게 기여하고 있어 고령 인구 증가가 도입을 더욱 가속화하고 있습니다. 이와 함께 의료기관과 시장 진출기업의 인식 개선 활동이 증가하면서 진단율과 치료율이 향상되고 있습니다. 무선 연결, 클라우드 기반 플랫폼, 모바일 지원 모니터링 등 첨단 기술의 통합으로 환자 참여도를 높이고 원격 치료 관리가 가능해졌습니다. 이러한 발전으로 치료 순응도 및 효과를 실시간으로 추적할 수 있게 되어 장기적인 치료 결과를 개선할 수 있게 되었습니다. 수면무호흡증용 기기는 기도 확보, 산소 공급 개선, 수면의 질 향상에 중요한 역할을 하며, 이를 통해 관련 건강 위험을 최소화하고 환자의 전반적인 건강을 지원합니다.
| 시장 범위 | |
|---|---|
| 개시 연도 | 2025년 |
| 예측 기간 | 2026-2035년 |
| 개시 연도 시장 규모 | 93억 달러 |
| 예측 시장 규모 | 187억 달러 |
| CAGR | 7.2% |
치료 장비 부문은 치료의 편의성과 효과성을 향상시키기 위한 지속적인 혁신에 힘입어 2025년 66.3%의 점유율을 차지했습니다. 첨단 치료 장비는 사용 편의성 및 성능 향상을 통해 환자의 순응도 향상과 장기적인 치료 성공에 기여하고 있습니다.
수면 검사실 및 병원 부문은 CAGR 6.3%로 성장하여, 2035년까지 70억 달러에 달할 것으로 예측됩니다. 이 부문의 성장은 임상적으로 관리되는 진단 및 치료 솔루션에 대한 수요 증가로 인해 주도되고 있습니다. 정확한 진단과 체계적인 치료 경로에 대한 요구가 의료시설 전반으로 확대되고 있습니다.
미국의 수면무호흡증용 기기 시장은 2025년 39억 달러로 평가되었습니다. 시장의 성장은 유리한 상환 제도와 편리한 진단 방법의 보급에 의해 뒷받침되고 있습니다. 접근하기 쉬운 검사 및 치료 솔루션으로의 전환은 환자 참여를 촉진하고 시장 전체에 대한 도달 범위를 확장하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법
제2장 주요 요약
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추산 및 예측 : 제품별(2022-2035년)
제6장 시장 추산 및 예측 : 최종 용도별(2022-2035년)
제7장 시장 추산 및 예측 : 지역별(2022-2035년)
제8장 기업 개요
AJY 26.06.11The Global Sleep Apnea Devices Market was valued at USD 9.3 billion in 2025 and is estimated to grow at a CAGR of 7.2% to reach USD 18.7 billion by 2035.
The sleep apnea devices industry is experiencing steady expansion due to the increasing prevalence of sleep-related breathing disorders, rising awareness levels, and continuous technological innovation. Growing demand for compact, efficient, and high-performance therapeutic solutions is reshaping the market landscape. The rising geriatric population is further accelerating adoption, as age-related conditions significantly contribute to sleep disorders. In parallel, increasing educational initiatives by healthcare institutions and industry participants are improving diagnosis and treatment rates. Integration of advanced technologies, including wireless connectivity, cloud-based platforms, and mobile-enabled monitoring, is enhancing patient engagement and enabling remote therapy management. These advancements allow real-time tracking of treatment adherence and effectiveness, improving long-term outcomes. Sleep apnea devices play a crucial role in maintaining airway patency, improving oxygen supply, and enhancing sleep quality, thereby minimizing associated health risks and supporting overall patient well-being.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $9.3 Billion |
| Forecast Value | $18.7 Billion |
| CAGR | 7.2% |
The therapeutics segment held a share of 66.3% in 2025, supported by continuous innovation aimed at improving treatment comfort and effectiveness. Advanced therapeutic devices now incorporate enhanced usability features and improved performance capabilities, contributing to better patient compliance and long-term therapy success.
The sleep laboratories and hospitals segment is anticipated to grow at a CAGR of 6.3%, reaching USD 7 billion by 2035. Growth in this segment is driven by increasing demand for clinically supervised diagnostic and treatment solutions. The need for accurate diagnosis and structured treatment pathways continues to support expansion across healthcare facilities.
U.S. Sleep Apnea Devices Market was valued at USD 3.9 billion in 2025. Market growth is supported by favorable reimbursement frameworks and increasing adoption of convenient diagnostic approaches. The shift toward accessible testing and treatment solutions is enhancing patient participation and expanding overall market reach.
Key players involved in the Global Sleep Apnea Devices Market include Apnea Sciences, Asahi KASEI, BMC, Cadwell, Drive DeVilbiss, DynaFlex, FISHER & PAYKEL, Glidewell, natus, NIHON KOHDEN, Philips, ResMed, SomnoMed, Teleflex, WEINMANN Top of FormBottom of Form. Companies in the Sleep Apnea Devices Market are focusing on innovation, strategic partnerships, and product portfolio expansion to strengthen their competitive position. Manufacturers are investing heavily in research and development to introduce technologically advanced and patient-friendly devices. Integration of digital health capabilities, including remote monitoring and data analytics, is becoming a key differentiator. Firms are also pursuing collaborations with healthcare providers and distributors to expand their global footprint. In addition, companies are emphasizing cost optimization, regulatory compliance, and improved supply chain efficiency to enhance accessibility and market penetration. Continuous focus on user-centric design and long-term therapy effectiveness is further supporting sustained growth and brand loyalty.
Table of Contents
Chapter 1 Research Methodology
- 1.1 Research approach
- 1.2 Quality commitments
- 1.2.1 GMI AI policy & data integrity commitment
- 1.2.1.1 Source consistency protocol
- 1.2.1 GMI AI policy & data integrity commitment
- 1.3 Research trail & confidence scoring
- 1.3.1 Research trail components
- 1.3.2 Scoring components
- 1.4 Data collection
- 1.4.1 Partial list of primary sources
- 1.5 Data mining sources
- 1.5.1 Paid sources
- 1.5.1.1 Sources, by region
- 1.5.1 Paid sources
- 1.6 Base estimates and calculations
- 1.6.1 Base year calculation
- 1.7 Forecast model
- 1.7.1 Quantified market impact analysis
- 1.7.1.1 Mathematical impact of growth parameters on forecast
- 1.7.1 Quantified market impact analysis
- 1.8 Research transparency addendum
- 1.8.1 Source attribution framework
- 1.8.2 Quality assurance metrics
- 1.8.3 Our commitment to trust
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Product trends
- 2.2.3 End use trends
- 2.3 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing incidence of sleep apnea and related comorbidities
- 3.2.1.2 Growing demand for portable, high-performance sleep apnea solutions
- 3.2.1.3 Surging awareness of sleep apnea and sleep disorders
- 3.2.1.4 The rising aging population amplifying demand
- 3.2.1.5 Technological advancements
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Lack of adherence to sleep apnea treatment
- 3.2.2.2 Product recalls and safety concerns
- 3.2.3 Opportunities
- 3.2.3.1 Expansion into emerging markets
- 3.2.3.2 AI and digital health integration
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape (Driven by Primary Research)
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.5 Technology and innovation landscape
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
- 3.6 Future market trends (Driven by Primary Research)
- 3.7 Reimbursement scenario
- 3.8 Gap analysis
- 3.9 Porter's analysis
- 3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.1.1 SOMNOMED LIMITED
- 4.1.2 FISHER & PAYKEL Healthcare
- 4.1.3 ResMed Inc.
- 4.2 Company matrix analysis
- 4.3 Company market share analysis (Driven by Primary Research)
- 4.3.1 Global
- 4.3.2 North America
- 4.3.3 Europe
- 4.3.4 Asia Pacific
- 4.3.5 Latin America
- 4.3.6 MEA
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New product launches
- 4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)
- 5.1 Key trends
- 5.2 Therapeutics
- 5.2.1 Positive airway pressure (PAP) devices
- 5.2.1.1 Continuous positive airway pressure (CPAP) devices
- 5.2.1.2 Automatic positive airway pressure (APAP) devices
- 5.2.1.3 Bilevel positive airway pressure (BiPAP) devices
- 5.2.2 Oral appliances
- 5.2.2.1 Mandibular advancement devices
- 5.2.2.2 Tongue-retaining devices
- 5.2.3 Adaptive servo-ventilation (ASV) devices
- 5.2.4 Airway clearance systems
- 5.2.5 Other therapeutic products
- 5.2.1 Positive airway pressure (PAP) devices
- 5.3 Diagnostics
- 5.3.1 Home sleep testing (HST) devices
- 5.3.1.1 Type 2
- 5.3.1.2 Type 3
- 5.3.1.3 Type 4
- 5.3.2 Polysomnography (PSG) device
- 5.3.2.1 Clinical PSG devices
- 5.3.2.2 Ambulatory PSG devices
- 5.3.3 Actigraphy systems
- 5.3.4 Other diagnostic devices
- 5.3.1 Home sleep testing (HST) devices
Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)
- 6.1 Key trends
- 6.2 Home care settings and individuals
- 6.3 Sleep laboratories and hospitals
Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)
- 7.1 Key trends
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.6 MEA
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
Chapter 8 Company Profiles
- 8.1 Apnea Sciences
- 8.2 Asahi KASEI
- 8.3 BMC
- 8.4 Cadwell
- 8.5 Drive DeVilbiss
- 8.6 DynaFlex
- 8.7 FISHER & PAYKEL
- 8.8 Glidewell
- 8.9 natus
- 8.10 NIHON KOHDEN
- 8.11 Philips
- 8.12 ResMed
- 8.13 SomnoMed
- 8.14 Teleflex
- 8.15 WEINMANN
